HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas R O'Brien Selected Research

Cytokines

11/2014IFN-λ4: the paradoxical new member of the interferon lambda family.
6/2003Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas R O'Brien Research Topics

Disease

21Infections
12/2020 - 01/2003
12Chronic Hepatitis C
01/2020 - 10/2008
8Fibrosis (Cirrhosis)
11/2021 - 12/2007
6Hepatitis C
09/2018 - 06/2009
5Neoplasms (Cancer)
11/2019 - 03/2004
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2011
4Virus Diseases (Viral Diseases)
03/2020 - 06/2009
4Acquired Immunodeficiency Syndrome (AIDS)
07/2010 - 12/2002
3Liver Neoplasms (Liver Cancer)
01/2020 - 07/2006
3Disease Progression
10/2017 - 02/2003
2Liver Diseases (Liver Disease)
11/2021 - 05/2004
2COVID-19
12/2020 - 01/2020
2Hepatitis B
11/2019 - 07/2012
2Communicable Diseases (Infectious Diseases)
10/2019 - 05/2008
2Viremia
01/2018 - 07/2012
1Chronic Hepatitis B
11/2021
1HIV Infections (HIV Infection)
01/2020
1Coinfection
01/2019
1Hepatitis D
01/2018
1Persistent Infection
01/2018
1Ulcer
01/2015
1Herpes Genitalis (Genital Herpes)
01/2015
1Mannose-Binding Protein Deficiency
05/2008
1Biliary Tract Neoplasms (Biliary Tract Cancer)
04/2008
1Hepatitis
09/2007
1Inflammation (Inflammations)
09/2006
1Sepsis (Septicemia)
09/2006
1Hypertension (High Blood Pressure)
01/2006
1Varicella Zoster Virus Infection
03/2002

Drug/Important Bio-Agent (IBA)

9Antiviral Agents (Antivirals)IBA
01/2020 - 03/2004
8InterferonsIBA
12/2020 - 06/2009
8RNA (Ribonucleic Acid)IBA
01/2019 - 05/2008
6Interferon LambdaIBA
12/2020 - 10/2009
5Ribavirin (Virazole)FDA LinkGeneric
06/2014 - 06/2009
5Pharmaceutical PreparationsIBA
07/2012 - 03/2003
4Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019 - 04/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 10/2008
3Interferon-alpha (Interferon Alfa)IBA
06/2014 - 06/2009
3HLA-B Antigens (HLA-B)IBA
07/2010 - 12/2002
2Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2021
2DDTIBA
11/2019 - 07/2006
2sofosbuvir drug combination ledipasvirIBA
04/2015 - 12/2014
2AntibodiesIBA
01/2015 - 04/2008
2CytokinesIBA
11/2014 - 06/2003
2Caspase 12IBA
03/2007 - 09/2006
2CCR5 Receptors (CCR5 Receptor)IBA
01/2006 - 01/2003
2Chemokine ReceptorsIBA
01/2006 - 02/2003
1Interleukin-8 (Interleukin 8)IBA
11/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Alanine Transaminase (SGPT)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1oxidized low density lipoproteinIBA
01/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020
1Polychlorinated Biphenyls (PCBs)IBA
01/2020
1HDL LipoproteinsIBA
01/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2020
1InsecticidesIBA
11/2019
1Chlordan (Chlordane)IBA
11/2019
1nonachlorIBA
11/2019
1oxychlordaneIBA
11/2019
1Biological ProductsIBA
10/2019
1Aflatoxin B1 (Aflatoxin B)IBA
01/2019
1HLA-B57 antigenIBA
10/2017
1SofosbuvirIBA
06/2014
1Protease Inhibitors (Protease Inhibitor)IBA
06/2014
1Double-Stranded RNA (RNA, Double Stranded)IBA
02/2013
1EnzymesIBA
07/2012
1Epidermal Growth Factor (EGF)IBA
07/2011
1Protein Isoforms (Isoforms)IBA
07/2010
1Recombinant ProteinsIBA
07/2010
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
05/2008
1Surface Antigens (Surface Antigen)IBA
04/2008
1AntigensIBA
04/2008
1N-acetyltalosaminuronic acid (NAT)IBA
02/2008
1Enzyme Precursors (Zymogens)IBA
09/2006
1CaspasesIBA
09/2006
1Dichlorodiphenyl Dichloroethylene (DDE)IBA
07/2006
1CCR ReceptorsIBA
01/2006
1Circular DNAIBA
05/2004
1Interleukin-4 (Interleukin 4)IBA
06/2003
1A 19IBA
02/2003
1Immunoglobulin G (IgG)IBA
03/2002

Therapy/Procedure

6Therapeutics
01/2020 - 06/2009
1Duration of Therapy
11/2017